Back to Search

Pegfilgrastim (FULPHILA) – Uses, Dosage, and Brands in UAE

Brand Name: FULPHILA
Strength: 6 mg | Form: Solution For Injection
Price in UAE: AED 5078.00
Available in UAE pharmacies

About Pegfilgrastim (FULPHILA)

Class: | Hematopoietic agent; Granulocyte colony-stimulating factor (G-CSF) Use: | Used to reduce the incidence of infection, as manifested by febrile neutropenia, in patients receiving myelosuppressive chemotherapy for malignancies. Adult dose: | 6 mg administered as a single subcutaneous injection once per chemotherapy cycle, typically given 24 hours after chemotherapy. Pediatric dose: | 6 mg administered as a single subcutaneous injection once per chemotherapy cycle, for patients aged 1

Drug Class

Hematopoietic agent; Granulocyte colony-stimulating factor (G-CSF)

Uses & Indications

Used to reduce the incidence of infection, as manifested by febrile neutropenia, in patients receiving myelosuppressive chemotherapy for malignancies.

Storage Requirements

Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. Can be kept at room temperature (up to 25°C or 77°F) for up to 48 hours before use.

Manufacturer & Packaging

Manufacturer: MYLAN GmbH, SWITZERLAND

Package Size

Prefilled Syringe

Price & Supplier

Price in UAE: AED 5078.00

Dosage Information

Adult Dose

6 mg administered as a single subcutaneous injection once per chemotherapy cycle, typically given 24 hours after chemotherapy.

Pediatric Dose

6 mg administered as a single subcutaneous injection once per chemotherapy cycle, for patients aged 1 year and older.

Side Effects

Common side effects include bone pain, fatigue, headache, nausea, and injection site reactions (e.g., redness, swelling).

Contraindications & Precautions

Hypersensitivity to pegfilgrastim or any component of the formulation; history of serious allergic reactions to filgrastim or pegfilgrastim.

Important Warnings

Risk of splenic rupture; serious allergic reactions; potential for acute respiratory distress syndrome (ARDS); monitor for signs of infection; use caution in patients with sickle cell disease.

Related Medicines in Same Category

See also: Other Hematopoietic agent; Granulocyte colony-stimulating factor (G-CSF) medicines available in UAE pharmacies

Pegfilgrastim (NEULASTIM) XM22 Drug Substance - Lipegfilgrastim

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Hematopoietic agent; Granulocyte colony-stimulating factor (G-CSF) Medicines Browse All Categories